Journal
JOURNAL OF AUTOIMMUNITY
Volume 129, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jaut.2022.102816
Keywords
Memory Th17; Effector Th17/1; T-bet
Categories
Funding
- National Institutes of Health [P30EY003790, 106-V-A-002]
- Yin Shu-Tien Foundation through the Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Pro-gram [EY20889]
Ask authors/readers for more resources
This study reveals the important role and transformation process of Th17 cells in autoimmune diseases. During the acute phase, eTh17/1 cells are the principal effector precursor cells, while mTh17 cells play a critical role in the chronic phase.
Effector Th17 cells, including IFN-gamma-IL-17(+) (eTh17) and IFN-gamma+IL-17(+ )(eTh17/1) subsets, play critical pathogenic functions in the induction of autoimmunity. As acute inflammation subsides, a small proportion of the effectors survive and convert to memory Th17 cells (mTh17), which sustain chronic inflammation in autoimmune dis-eases. Herein, we investigated the differential contributions of eTh17 versus eTh17/1 to the memory pool using an experimental model of ocular autoimmune disease. Our results show that adoptive transfer of Tbx21-/- CD4+ T cells or conditional deletion of Tbx21 in Th17 cells leads to diminished eTh17/1 in acute phase and func-tionally compromised mTh17 in chronic phase. Further, adoptive transfer of disease-specific eTh17/1, but not eTh17, leads to generation of mTh17 and sustained ocular inflammation. Collectively, our data demonstrate that T-bet-dependent eTh17/1 cells generated during the acute inflammation are the principal effector precursors of pathogenic mTh17 cells that sustain the chronicity of autoimmune inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available